A - Human Necessities – 61 – P
Patent
A - Human Necessities
61
P
A61P 35/00 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2444219
The present invention provides combinations of a DNA topoisomerase I inhibiting agent and a selective COX-2 inhibiting agent for preventing, treating, and/or reducing the risk of developing a neoplasia disorder in a mammal.
La présente invention se rapporte à des combinaisons d'un agent inhibiteur de l'ADN topoisomérase I et d'un agent inhibiteur sélectif de la COX-2 permettant de prévenir, traiter et/ou réduire le risque de développement d'un trouble néoplasique chez un mammifère.
Cunningham James J.
Gately Stephen T.
Gordon Gary B.
Koki Alane T.
Masferrer Jaime L.
Osler Hoskin & Harcourt Llp
Pharmacia Corporation
LandOfFree
Antiangiogenic combination therapy for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiangiogenic combination therapy for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiangiogenic combination therapy for the treatment of cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1799368